Genetic Technologies (GENE) Stock: Gaining On Completion Of Genetic Risk Tests

Genetic Technologies GENE Stock News

Genetic Technologies Limited (NASDAQ: GENE) is having an incredibly strong start to the trading session this morning after the company announced the completion of genetic risk tests. Of course, the news excited investors who are pushing the stock for the top. Today, we’ll talk about: The genetic risk tests; what we’re seeing from GENE stock … Read more

Histogenics (HSGX) Stock: Continues Soaring On Partnership News!

Histogenix HSGX Stock News

Histogenics Corp (NASDAQ: HSGX) is having an incredibly strong start to the trading session this morning, following up on the incredible day that the stock had in the market yesterday. The gains came after the company announced a new partnership. Today, we’ll talk about: The partnership; what we’re seeing from HSGX stock as a result; … Read more

Bellerophon Therapeutics (BLPH) Stock: Rocketing On Regulatory Update

Bellerophon Therapeutics Inc BLPH Stock News

Bellerophon Therapeutics Inc (NASDAQ: BLPH) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced a regulatory update, exciting investors who are sending the stock for the top. Today, we’ll talk about: The regulatory update; what we’re seeing from BLPH stock as a result; and what … Read more

Palatin Technologies (PTN) Stock: Climbing On Clinical Data

Palatin Technologies PTN Stock News

Palatin Technologies, Inc. (NYSEAMERICAN: PTN) is having a great day in the market today, and for good reason. The company announced positive clinical data, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The clinical data; what we’re seeing from PTN stock as a result; and what we’ll … Read more

Tonix Pharmaceuticals (TNXP) Stock: Gaining On Expanded Phase 3 Program

Tonix Pharmaceuticals TNXP Stock News

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is making a run for the top in the market this morning, and for good reason. The comapny announced that it would be expanding a late-stage clinical development program. As you could imagine, the news excited investors, sending the stock on a run for the top. Today, we’ll talk … Read more

AVEO Pharmaceuticals (AVEO) Stock: Tumbling As Acquisition Rumors Prove False

AVEO Pharmaceuticals AVEO Stock News

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) had a strong run in the market earlier in the week as acquisition rumors took hold. Unfortunately however, the stock is down in a big way this morning after the company announced offering news. Not only does the offering dilute current shareholders, it serves as a point of clarity when … Read more

ADMA Biologics (ADMA) Stock: Rocketing On FDA Approval

ADMA Biologics ADMA Stock News

ADMA Biologics Inc (NASDAQ: ADMA) is making a run for the top in the market this morning, and for good reason. The company announced that it has received an FDA approval, meaning that it can now market its product in the United States. As you could imagine, the news excited investors, sending the stock screaming … Read more

Achieve Life Sciences (ACHV) Stock: Gaining On DSMC Review

Achieve Life Sciences Inc ACHV Stock News

Achieve Life Sciences Inc (NASDAQ: ACHV) is making a run for the top in the pre-market hours this morning, and for good reason. The company announced a positive result from a Data Safety Monitoring Committee (DSMC) review. As you could imagine, the news excited investors who are sending the stock on a run for the … Read more

AVEO Pharmaceuticals (AVEO) Stock: Gaining On Data

AVEO Pharmaceuticals AVEO Stock News

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is having a great start to the trading session in the pre-market this morning, following up on the strong gains that we saw yesterday. Today’s gains seem to be the result of data that was released. Today, we’ll talk about: The data release; what we’re seeing from AVEO stock as … Read more